Delavirdine dosage and administration: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Delavirdine}} {{CMG}}; {{AE}} {{AZ}} ==References== {{Reflist}} {{FDA}} Category:Antibiotics Category:Wikinfect")
 
No edit summary
Line 4: Line 4:




 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = RESCRIPTOR (DELAVIRDINE MESYLATE) TABLET [VIIV HEALTHCARE COMPANY] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb28dcd2-c457-4137-9eec-00062e5a601b | publisher =  | date =  | accessdate =  }}</ref>


==References==
==References==

Revision as of 22:36, 1 January 2014

Delavirdine
RESCRIPTOR® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]


[1]

References

  1. "RESCRIPTOR (DELAVIRDINE MESYLATE) TABLET [VIIV HEALTHCARE COMPANY]".

Adapted from the FDA Package Insert.